Research highlights
Vaccine
Promising results from a hepatitis E vaccine study in rural Bangladesh
Hepatitis E virus (HEV) is a major cause of acute viral hepatitis and is particularly harmful in low...
Clinical feature
HEV Infection in Liver Transplant Recipients in Sweden
Following exposure to hepatitis E virus (HEV), liver transplant recipients have increased risk of de...
Clinical feature
A Viennese case series of patients with acute hepatitis E showed that mortality is low – even in severe courses
The results of a recent study conducted at the Vienna General Hospital, led by Prof. Thomas Reiberge...
Diagnostics
Extracellular vesicle-derived ASS1 for predicting HEV-ALF occurrence
Hepatitis E virus (HEV) infection is usually a self-limiting disease, and the majority of infections...
Virology
Accurate atomic model of the hepatitis E virus pORF1
Structural biology, the field that produces atomic-level structures of biomacromolecules, has underg...
Animal reservoir
One health
Serological screening for HEV in camels in Kazakhstan
Until now, the camel was considered an ordinary farm animal with infectious diseases peculiar only t...
Animal reservoir
One health
HEV Infection in Cetaceans in Spain
Hepatitis E virus (HEV) is an emerging zoonotic pathogen with worldwide distribution that has been d...
Popular
One health
Rat HEV: a story by Dr. Siddharth Sridhar
Hepatitis E has always fascinated me. Epidemiologically, this virus is a shape-shifter, infecting hu...
Public health
Introducing a Chinese consortium of hepatitis E
CCSHE, The Chinese Consortium for the Study of Hepatitis E, is an academic association dedicated to ...
Public health
Hepatitis E Outbreaks among refugees and internally displaced persons in sub-Saharan Africa
It is often challenging to obtain the most up-to-date burden of infectious diseases among refugees...
Diagnostics
Mapping the changes of serum metabolites in HEV patients
In the past decade, acute liver failure (ALF) caused by hepatitis E virus (HEV) infection has become...
Experimental model
Human embryonic and induced pluripotent stem cell-derived HEV culture models
The heterogenous nature of hepatitis E virus (HEV) infections poses clinical challenges. Tropical HE...
Public health
A decade of HEV molecular surveillance in Germany, 2010–2019
Orthohepevirus A, also known as the hepatitis E virus (HEV), is endemic in Europe. HEV is divided in...
Diagnostics
Exosome-derived CPS1 for the diagnosis and prognosis of HEV-ALF
Although hepatitis E virus (HEV) infection is usually asymptomatic and results in a self-limited dis...
News
Call for Abstracts: International HEV Symposium in Istanbul
The International Vaccine Institute (Seoul, South Korea) is hosting a Hepatitis E Symposium this Apr...
Antiviral agent
PhD awarded to Yunlong Li on hepatitis E research
On 30 August, Yunlong Li defended his PhD thesis on the development of antiviral therapy for treatin...
Public health
Experience of the first HEV vaccination campaign
Hepatitis E outbreaks regularly occur during humanitarian emergencies, often leading to tens of thou...
Public health
Introducing a Chinese consortium of hepatitis E
CCSHE, The Chinese Consortium for the Study of Hepatitis E, is an academic association dedicated to ...
Clinical feature
Advancing chronic hepatitis E research and patient care
The hepatitis E virus (HEV) was initially thought to exclusively cause acute hepatitis. However, the...
Public health
Severe hepatitis in children of unknown origin – update in Journal of Hepatology
At the beginning of April 2022 10 cases of severe acute hepatitis of unknown origin in children <...
Public health
Hepatitis E in India
The study of hepatitis E is deeply intertwined with India. The existence of hepatitis E virus as a d...
About us
MISSION & VALUES
Global Hepatitis E Platform
The mission of the Global Hepatitis E Platform is to enhance the global awareness and knowledge about hepatitis E. We connect all stakeholders to join forces for advancing hepatitis E research, education, public health and patient care.
We promote transparency, objectivity and collaboration in pursuit of knowledge and insights, wherever this may lead us.
MANAGEMENT TEAM
EVENTS
2023-04-27
2nd International HEV Symposium
The meeting will be held from April 27 to 28, 2023, in Istanbul. The 2-day meeting will feature talks and presentations given on the latest updates on HEV epidemiology, diagnostics, treatment, laboratory research, and disease control. Abstract submission closes on February 24th at midnight (GMT). More information: https://www.ivi.int/hev-symposium-2023/
The meeting will be held from April 27 to 28, 2023, in Istanbul. The 2-day meeting will feature talks and presentations given on the latest updates on HEV epidemiology, diagnostics, treatment, laboratory research, and disease control. Abstract submission closes on February 24th at midnight (GMT). More information: https://www.ivi.int/hev-symposium-2023/
